vs
CLOVER HEALTH INVESTMENTS, CORP.（CLOV）与SCANSOURCE, INC.（SCSC）财务数据对比。点击上方公司名可切换其他公司
SCANSOURCE, INC.的季度营收约是CLOVER HEALTH INVESTMENTS, CORP.的1.6倍（$766.5M vs $487.7M），SCANSOURCE, INC.净利率更高（2.2% vs -10.1%，领先12.3%），CLOVER HEALTH INVESTMENTS, CORP.同比增速更快（44.7% vs 2.5%），SCANSOURCE, INC.自由现金流更多（$28.9M vs $-69.0M），过去两年CLOVER HEALTH INVESTMENTS, CORP.的营收复合增速更高（18.6% vs 0.9%）
克利弗健康投资公司是2014年成立的美国医疗保健企业，主营联邦医疗保险优势计划保险产品，是与美国政府直接签约合作的机构。目前公司为美国11个州的联邦医疗保险参保人提供健康管理服务，并已于2021年1月8日公开上市。
ScanSource是全球领先的专业技术分销商，主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案，面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户，覆盖零售、医疗、工业、公共部门等领域。
CLOV vs SCSC — 直观对比
营收规模更大
SCSC
是对方的1.6倍
$487.7M
营收增速更快
CLOV
高出42.2%
2.5%
净利率更高
SCSC
高出12.3%
-10.1%
自由现金流更多
SCSC
多$97.8M
$-69.0M
两年增速更快
CLOV
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $487.7M | $766.5M |
| 净利润 | $-49.3M | $16.5M |
| 毛利率 | — | 13.4% |
| 营业利润率 | -10.1% | 2.3% |
| 净利率 | -10.1% | 2.2% |
| 营收同比 | 44.7% | 2.5% |
| 净利润同比 | -123.2% | -3.3% |
| 每股收益（稀释后） | — | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLOVSCSC
| Q4 25 | $487.7M | $766.5M | ||
| Q3 25 | $496.6M | $739.6M | ||
| Q2 25 | $477.6M | $812.9M | ||
| Q1 25 | $462.3M | $704.8M | ||
| Q4 24 | $337.0M | $747.5M | ||
| Q3 24 | $331.0M | $775.6M | ||
| Q2 24 | $356.3M | $746.1M | ||
| Q1 24 | $346.9M | $752.6M |
净利润CLOVSCSC
| Q4 25 | $-49.3M | $16.5M | ||
| Q3 25 | $-24.4M | $19.9M | ||
| Q2 25 | $-10.6M | $20.1M | ||
| Q1 25 | $-1.3M | $17.4M | ||
| Q4 24 | $-22.1M | $17.1M | ||
| Q3 24 | $-9.2M | $17.0M | ||
| Q2 24 | $7.4M | $16.1M | ||
| Q1 24 | $-19.2M | $12.8M |
毛利率CLOVSCSC
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | 24.5% | 13.1% | ||
| Q2 24 | 30.3% | 13.0% | ||
| Q1 24 | 23.6% | 12.6% |
营业利润率CLOVSCSC
| Q4 25 | -10.1% | 2.3% | ||
| Q3 25 | -4.9% | 3.5% | ||
| Q2 25 | -2.2% | 3.3% | ||
| Q1 25 | -0.3% | 3.2% | ||
| Q4 24 | -6.4% | 2.5% | ||
| Q3 24 | -2.7% | 2.3% | ||
| Q2 24 | 2.0% | 2.9% | ||
| Q1 24 | -6.5% | 2.3% |
净利率CLOVSCSC
| Q4 25 | -10.1% | 2.2% | ||
| Q3 25 | -4.9% | 2.7% | ||
| Q2 25 | -2.2% | 2.5% | ||
| Q1 25 | -0.3% | 2.5% | ||
| Q4 24 | -6.6% | 2.3% | ||
| Q3 24 | -2.8% | 2.2% | ||
| Q2 24 | 2.1% | 2.2% | ||
| Q1 24 | -5.5% | 1.7% |
每股收益（稀释后）CLOVSCSC
| Q4 25 | — | $0.75 | ||
| Q3 25 | — | $0.89 | ||
| Q2 25 | — | $0.87 | ||
| Q1 25 | — | $0.74 | ||
| Q4 24 | — | $0.70 | ||
| Q3 24 | — | $0.69 | ||
| Q2 24 | — | $0.66 | ||
| Q1 24 | — | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $78.3M | $83.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $308.7M | $910.9M |
| 总资产 | $541.0M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLOVSCSC
| Q4 25 | $78.3M | $83.5M | ||
| Q3 25 | — | $124.9M | ||
| Q2 25 | — | $126.2M | ||
| Q1 25 | — | $146.3M | ||
| Q4 24 | $194.5M | $110.5M | ||
| Q3 24 | $288.0M | $145.0M | ||
| Q2 24 | $254.8M | $185.5M | ||
| Q1 24 | $208.3M | $159.1M |
股东权益CLOVSCSC
| Q4 25 | $308.7M | $910.9M | ||
| Q3 25 | $340.9M | $914.0M | ||
| Q2 25 | $344.2M | $906.4M | ||
| Q1 25 | $336.1M | $901.7M | ||
| Q4 24 | $341.1M | $900.7M | ||
| Q3 24 | $342.2M | $920.9M | ||
| Q2 24 | $324.9M | $924.3M | ||
| Q1 24 | $292.5M | $944.1M |
总资产CLOVSCSC
| Q4 25 | $541.0M | $1.7B | ||
| Q3 25 | $559.7M | $1.7B | ||
| Q2 25 | $575.0M | $1.8B | ||
| Q1 25 | $583.7M | $1.7B | ||
| Q4 24 | $580.7M | $1.7B | ||
| Q3 24 | $653.0M | $1.8B | ||
| Q2 24 | $674.2M | $1.8B | ||
| Q1 24 | $671.8M | $1.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-66.9M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $-69.0M | $28.9M |
| 自由现金流率自由现金流/营收 | -14.1% | 3.8% |
| 资本支出强度资本支出/营收 | 0.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.87× |
| 过去12个月自由现金流最近4个季度 | $-69.2M | — |
8季度趋势，按日历期对齐
经营现金流CLOVSCSC
| Q4 25 | $-66.9M | $30.8M | ||
| Q3 25 | $12.1M | $23.2M | ||
| Q2 25 | $5.4M | — | ||
| Q1 25 | $-16.3M | $66.1M | ||
| Q4 24 | $34.8M | $-6.2M | ||
| Q3 24 | $50.0M | $44.8M | ||
| Q2 24 | $44.8M | — | ||
| Q1 24 | $25.9M | $160.2M |
自由现金流CLOVSCSC
| Q4 25 | $-69.0M | $28.9M | ||
| Q3 25 | $11.4M | $20.8M | ||
| Q2 25 | $4.8M | — | ||
| Q1 25 | $-16.5M | $64.6M | ||
| Q4 24 | $33.3M | $-8.2M | ||
| Q3 24 | $49.6M | $42.5M | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | $157.7M |
自由现金流率CLOVSCSC
| Q4 25 | -14.1% | 3.8% | ||
| Q3 25 | 2.3% | 2.8% | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | -3.6% | 9.2% | ||
| Q4 24 | 9.9% | -1.1% | ||
| Q3 24 | 15.0% | 5.5% | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | 21.0% |
资本支出强度CLOVSCSC
| Q4 25 | 0.4% | 0.3% | ||
| Q3 25 | 0.1% | 0.3% | ||
| Q2 25 | 0.1% | 0.3% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.5% | 0.3% | ||
| Q3 24 | 0.1% | 0.3% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.3% |
现金转化率CLOVSCSC
| Q4 25 | — | 1.87× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | — | 2.64× | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | 12.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLOV
暂无分部数据
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
